Article
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression
17 Aug 2018
Abstract excerpt
Expression levels of retinoic acid receptor gamma (NR1B3/RARG, encodes RARγ) are commonly reduced in prostate cancer (PCa). Therefore, we sought to establish the cellular and gene regulatory consequences of reduced RARγ expression, and determine RARγ regulatory mechanisms. RARG shRNA approaches in non-malignant (RWPE-1 and HPr1-AR) and malignant (LNCaP) prostate models revealed that reducing RARγ levels, rather...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
